| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 29 | 2022 | 685 | 4.690 |
Why?
|
| Proteomics | 22 | 2020 | 489 | 3.160 |
Why?
|
| Biomarkers, Tumor | 18 | 2021 | 1460 | 2.640 |
Why?
|
| Carcinoma, Pancreatic Ductal | 11 | 2021 | 153 | 2.620 |
Why?
|
| Proteome | 11 | 2021 | 241 | 2.480 |
Why?
|
| Colitis, Ulcerative | 8 | 2016 | 208 | 1.890 |
Why?
|
| Colorectal Neoplasms | 5 | 2016 | 566 | 1.100 |
Why?
|
| Glycoproteins | 9 | 2018 | 369 | 1.060 |
Why?
|
| Neoplasm Proteins | 7 | 2020 | 669 | 1.000 |
Why?
|
| Adenocarcinoma | 10 | 2019 | 998 | 0.990 |
Why?
|
| Proteins | 4 | 2020 | 1043 | 0.770 |
Why?
|
| Pancreatic Juice | 3 | 2015 | 5 | 0.750 |
Why?
|
| Disease Progression | 9 | 2019 | 2038 | 0.690 |
Why?
|
| Mass Spectrometry | 10 | 2018 | 331 | 0.680 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 17 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 619 | 0.660 |
Why?
|
| Genes, Homeobox | 1 | 2019 | 70 | 0.640 |
Why?
|
| Cytoskeletal Proteins | 3 | 2012 | 268 | 0.630 |
Why?
|
| Colon | 5 | 2016 | 353 | 0.620 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 129 | 0.600 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2014 | 1900 | 0.600 |
Why?
|
| Phosphoproteins | 3 | 2012 | 404 | 0.600 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 138 | 0.590 |
Why?
|
| Diazooxonorleucine | 1 | 2017 | 1 | 0.580 |
Why?
|
| Deoxycytidine | 1 | 2017 | 76 | 0.560 |
Why?
|
| Glycomics | 1 | 2016 | 15 | 0.550 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 211 | 0.540 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 3342 | 0.530 |
Why?
|
| Glutamine | 1 | 2017 | 210 | 0.520 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 546 | 0.520 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 211 | 0.500 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 692 | 0.490 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 247 | 0.480 |
Why?
|
| Body Fluids | 1 | 2015 | 47 | 0.480 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2014 | 35 | 0.470 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2012 | 118 | 0.470 |
Why?
|
| Cell Movement | 5 | 2014 | 835 | 0.470 |
Why?
|
| Carcinoma | 3 | 2018 | 280 | 0.470 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2012 | 150 | 0.460 |
Why?
|
| Cell Proliferation | 5 | 2019 | 2303 | 0.450 |
Why?
|
| Carrier Proteins | 4 | 2017 | 1024 | 0.450 |
Why?
|
| Rectum | 1 | 2014 | 98 | 0.450 |
Why?
|
| Pancreatitis, Chronic | 3 | 2011 | 68 | 0.440 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2019 | 538 | 0.430 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 723 | 0.420 |
Why?
|
| Galectin 1 | 1 | 2012 | 2 | 0.410 |
Why?
|
| Precancerous Conditions | 3 | 2016 | 283 | 0.400 |
Why?
|
| Immunohistochemistry | 10 | 2014 | 1684 | 0.400 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2014 | 236 | 0.400 |
Why?
|
| Humans | 54 | 2022 | 124326 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 383 | 0.390 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 426 | 0.390 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 662 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 467 | 0.380 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 109 | 0.380 |
Why?
|
| Pancreatitis | 3 | 2014 | 130 | 0.380 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 775 | 0.360 |
Why?
|
| Survival Analysis | 1 | 2014 | 1482 | 0.360 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 217 | 0.350 |
Why?
|
| Carcinoma in Situ | 2 | 2010 | 67 | 0.350 |
Why?
|
| MicroRNAs | 3 | 2016 | 840 | 0.340 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 430 | 0.340 |
Why?
|
| Cell Adhesion Molecules | 2 | 2016 | 224 | 0.330 |
Why?
|
| DNA Fingerprinting | 3 | 2005 | 107 | 0.330 |
Why?
|
| Peptidylprolyl Isomerase | 3 | 2014 | 37 | 0.310 |
Why?
|
| Genomic Instability | 2 | 2012 | 229 | 0.310 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 548 | 0.310 |
Why?
|
| Death-Associated Protein Kinases | 3 | 2020 | 6 | 0.300 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1272 | 0.300 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2008 | 92 | 0.290 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 68 | 0.290 |
Why?
|
| Thy-1 Antigens | 2 | 2020 | 21 | 0.290 |
Why?
|
| ras Proteins | 1 | 2008 | 136 | 0.290 |
Why?
|
| Glycosylation | 6 | 2021 | 119 | 0.290 |
Why?
|
| Fibroblasts | 1 | 2012 | 889 | 0.280 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 355 | 0.260 |
Why?
|
| Prognosis | 4 | 2019 | 4554 | 0.260 |
Why?
|
| HeLa Cells | 5 | 2014 | 809 | 0.260 |
Why?
|
| Oxidative Stress | 4 | 2021 | 813 | 0.250 |
Why?
|
| Down-Regulation | 4 | 2020 | 701 | 0.240 |
Why?
|
| Phosphorylation | 5 | 2020 | 1625 | 0.240 |
Why?
|
| Carcinogenesis | 2 | 2019 | 334 | 0.240 |
Why?
|
| Cell Survival | 4 | 2021 | 806 | 0.240 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 66 | 0.230 |
Why?
|
| Transcription Factors | 1 | 2014 | 2607 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2008 | 820 | 0.220 |
Why?
|
| ROC Curve | 4 | 2018 | 562 | 0.210 |
Why?
|
| Neoplasm Invasiveness | 3 | 2012 | 606 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 549 | 0.200 |
Why?
|
| Myeloid Cells | 2 | 2020 | 100 | 0.200 |
Why?
|
| Signal Transduction | 7 | 2020 | 4532 | 0.200 |
Why?
|
| Neutrophil Infiltration | 1 | 2022 | 64 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 816 | 0.190 |
Why?
|
| Biopsy | 3 | 2016 | 1237 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 172 | 0.190 |
Why?
|
| Glycation End Products, Advanced | 1 | 2021 | 20 | 0.180 |
Why?
|
| Glyceraldehyde | 1 | 2021 | 28 | 0.180 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 2507 | 0.180 |
Why?
|
| Osteoblasts | 1 | 2002 | 150 | 0.180 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 28 | 0.180 |
Why?
|
| Stromal Cells | 2 | 2012 | 299 | 0.180 |
Why?
|
| Animals | 13 | 2020 | 34134 | 0.170 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 3 | 2014 | 28 | 0.170 |
Why?
|
| Neutrophils | 1 | 2022 | 378 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 130 | 0.170 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 356 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 185 | 0.160 |
Why?
|
| HT29 Cells | 2 | 2020 | 45 | 0.160 |
Why?
|
| Mutation | 7 | 2019 | 5807 | 0.160 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 64 | 0.160 |
Why?
|
| Nitric Oxide | 1 | 2002 | 444 | 0.160 |
Why?
|
| Mice, Nude | 2 | 2012 | 710 | 0.160 |
Why?
|
| Cell Cycle | 2 | 2019 | 616 | 0.150 |
Why?
|
| Inflammation | 1 | 2005 | 1410 | 0.150 |
Why?
|
| Cell Line | 4 | 2014 | 2770 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2014 | 3268 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2010 | 1108 | 0.140 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 382 | 0.140 |
Why?
|
| DNA | 1 | 2003 | 1598 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 4 | 2005 | 1584 | 0.140 |
Why?
|
| Peptide Library | 1 | 2017 | 56 | 0.140 |
Why?
|
| DNA Replication | 1 | 2019 | 350 | 0.140 |
Why?
|
| Tissue Array Analysis | 2 | 2014 | 137 | 0.140 |
Why?
|
| Neoplasms | 1 | 2012 | 2794 | 0.140 |
Why?
|
| Drug Synergism | 1 | 2017 | 232 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1017 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 188 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 445 | 0.130 |
Why?
|
| Epidermal Growth Factor | 2 | 2008 | 122 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1064 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2016 | 1000 | 0.130 |
Why?
|
| Apoptosis | 3 | 2021 | 1790 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2016 | 753 | 0.120 |
Why?
|
| Cyst Fluid | 1 | 2015 | 6 | 0.120 |
Why?
|
| Peptides | 2 | 2017 | 793 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2016 | 170 | 0.120 |
Why?
|
| Bile | 1 | 2015 | 46 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 2699 | 0.120 |
Why?
|
| Blood Proteins | 2 | 2015 | 116 | 0.120 |
Why?
|
| Pancreatic Cyst | 1 | 2015 | 30 | 0.120 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2014 | 12 | 0.120 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 670 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 198 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 101 | 0.110 |
Why?
|
| Plectin | 1 | 2013 | 2 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2017 | 236 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 274 | 0.110 |
Why?
|
| Models, Biological | 2 | 2012 | 1459 | 0.110 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 3873 | 0.110 |
Why?
|
| Exosomes | 1 | 2013 | 43 | 0.110 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 1218 | 0.110 |
Why?
|
| Area Under Curve | 2 | 2012 | 315 | 0.100 |
Why?
|
| Sumoylation | 1 | 2013 | 37 | 0.100 |
Why?
|
| Tissue Fixation | 1 | 2013 | 38 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 61 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 113 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2016 | 418 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 2871 | 0.100 |
Why?
|
| Cell-Matrix Junctions | 1 | 2012 | 8 | 0.100 |
Why?
|
| Middle Aged | 5 | 2019 | 26442 | 0.100 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 254 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 862 | 0.100 |
Why?
|
| Mice | 7 | 2016 | 17723 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2012 | 75 | 0.090 |
Why?
|
| Young Adult | 2 | 2019 | 8978 | 0.090 |
Why?
|
| Biological Specimen Banks | 1 | 2011 | 51 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2020 | 623 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2122 | 0.090 |
Why?
|
| Neoplastic Processes | 1 | 2010 | 6 | 0.090 |
Why?
|
| CA-19-9 Antigen | 1 | 2010 | 10 | 0.090 |
Why?
|
| Biomarkers | 3 | 2015 | 2977 | 0.090 |
Why?
|
| Mucoproteins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Osteopontin | 1 | 2010 | 49 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 300 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5106 | 0.080 |
Why?
|
| Male | 6 | 2019 | 60987 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 199 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2008 | 3050 | 0.080 |
Why?
|
| Actins | 1 | 2012 | 342 | 0.080 |
Why?
|
| Oncogene Proteins | 1 | 2010 | 137 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2012 | 1400 | 0.080 |
Why?
|
| DNA Primers | 3 | 2013 | 660 | 0.080 |
Why?
|
| Catalytic Domain | 2 | 2011 | 157 | 0.080 |
Why?
|
| Pancreas | 4 | 2013 | 217 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2013 | 124 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2016 | 1530 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 328 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6467 | 0.070 |
Why?
|
| Immunoblotting | 2 | 2013 | 313 | 0.070 |
Why?
|
| Aged | 3 | 2019 | 19460 | 0.070 |
Why?
|
| Female | 7 | 2019 | 66264 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1674 | 0.070 |
Why?
|
| Adolescent | 2 | 2019 | 19354 | 0.070 |
Why?
|
| Plasminogen | 1 | 2007 | 7 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2007 | 17 | 0.070 |
Why?
|
| Adult | 5 | 2019 | 29378 | 0.070 |
Why?
|
| Time Factors | 2 | 2014 | 6262 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2006 | 57 | 0.070 |
Why?
|
| Enzymes | 1 | 2007 | 52 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 767 | 0.070 |
Why?
|
| Fibrinogen | 1 | 2007 | 152 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 1006 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 176 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 354 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 1015 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2005 | 124 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 2004 | 1 | 0.060 |
Why?
|
| Paxillin | 1 | 2004 | 10 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 151 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2005 | 204 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2004 | 55 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 369 | 0.060 |
Why?
|
| Computational Biology | 3 | 2019 | 818 | 0.060 |
Why?
|
| COS Cells | 1 | 2004 | 276 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 240 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2004 | 290 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 153 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3754 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 195 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 391 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 764 | 0.050 |
Why?
|
| Risk Factors | 2 | 2016 | 10139 | 0.050 |
Why?
|
| Protein Binding | 2 | 2020 | 1747 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 755 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1321 | 0.050 |
Why?
|
| Centrosome | 2 | 2013 | 35 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 43 | 0.050 |
Why?
|
| Lumican | 2 | 2012 | 4 | 0.050 |
Why?
|
| Keratan Sulfate | 2 | 2012 | 7 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 54 | 0.050 |
Why?
|
| Nitroprusside | 1 | 2002 | 46 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2012 | 27 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 69 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 98 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 137 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2012 | 37 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2019 | 16223 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2002 | 253 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2002 | 360 | 0.050 |
Why?
|
| Skull | 1 | 2002 | 142 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2020 | 6 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2020 | 22 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2020 | 41 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2020 | 19 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2020 | 146 | 0.040 |
Why?
|
| Biodiversity | 1 | 2019 | 64 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2020 | 334 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Werner Syndrome | 1 | 1997 | 1 | 0.040 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 1997 | 8 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 219 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 2029 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 168 | 0.040 |
Why?
|
| Mutagens | 1 | 1997 | 84 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1887 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 671 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 554 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 297 | 0.030 |
Why?
|
| Transfection | 2 | 2011 | 1069 | 0.030 |
Why?
|
| DNA Helicases | 1 | 1997 | 226 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 48 | 0.030 |
Why?
|
| Protein Phosphatase 2 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3133 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1995 | 18 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 95 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 325 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 97 | 0.030 |
Why?
|
| Heterozygote | 1 | 1997 | 676 | 0.030 |
Why?
|
| DNA Damage | 1 | 1998 | 514 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 80 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 3687 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 141 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 196 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 290 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 314 | 0.030 |
Why?
|
| Colitis | 1 | 2016 | 154 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2014 | 20 | 0.030 |
Why?
|
| Mucin 5AC | 1 | 2014 | 24 | 0.030 |
Why?
|
| Software | 1 | 2019 | 685 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 298 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 121 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 98 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 886 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 511 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 58 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 112 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2013 | 114 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 374 | 0.030 |
Why?
|
| Proto-Oncogenes | 2 | 2006 | 37 | 0.020 |
Why?
|
| Exonucleases | 1 | 2012 | 23 | 0.020 |
Why?
|
| Gelsolin | 1 | 2012 | 13 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2012 | 44 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1341 | 0.020 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2011 | 7 | 0.020 |
Why?
|
| Acinar Cells | 1 | 2011 | 9 | 0.020 |
Why?
|
| Versicans | 1 | 2011 | 12 | 0.020 |
Why?
|
| Contrast Media | 1 | 2015 | 476 | 0.020 |
Why?
|
| Exoribonucleases | 1 | 2012 | 23 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 393 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2012 | 54 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1132 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1018 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2011 | 58 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 802 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1612 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 93 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 151 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 187 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4423 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 117 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 84 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2011 | 133 | 0.020 |
Why?
|
| Adipokines | 1 | 2011 | 58 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 403 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 314 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 173 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 573 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1182 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2824 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1694 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4730 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 928 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 677 | 0.020 |
Why?
|
| Pedigree | 2 | 2006 | 1596 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 749 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2087 | 0.020 |
Why?
|
| Actinin | 1 | 2006 | 4 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1995 | 822 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 943 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 314 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2006 | 178 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3576 | 0.010 |
Why?
|
| Base Sequence | 2 | 1998 | 3093 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1998 | 192 | 0.010 |
Why?
|
| Werner Syndrome Helicase | 1 | 1997 | 2 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 180 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 1997 | 51 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 1997 | 60 | 0.010 |
Why?
|
| Homozygote | 1 | 1997 | 533 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 124 | 0.010 |
Why?
|
| DNA Repair | 1 | 1998 | 589 | 0.010 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 1995 | 34 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1997 | 525 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1995 | 247 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 1687 | 0.010 |
Why?
|
| Point Mutation | 1 | 1995 | 348 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1995 | 492 | 0.010 |
Why?
|
| Phenotype | 1 | 1997 | 4255 | 0.000 |
Why?
|